Marie Claire

CELEBRITY STYLE SPY: See all the latest celeb photos Stars animation


New drug = longer lashes

Marie Claire Beauty News: Mascara

A drug developed to treat glaucoma has now been licensed for cosmetic use, after it was discovered that it gave users bambi-like eyelashes.

Created by Allergan, the drug company that is also behind Botox, Latisse could hit UK shops next year, as a lash-lengthening treatment that could be worth millions for the firm.

Originally used as a glaucoma medicine, the ingredient was found to have an eyelash-enhancing side effect in users, lengthening lashes, as well as making them thicker and darker in a matter of days.

Allergan is now fiercely protecting its wonder product and has already taken legal action against seven cosmetic companies that attempted to create products that included Latisse's active ingredient, prostaglandins.

Speaking to the Independent, Valerie Randall, professor of biomedical sciences at the University of Bradford, said: 'I imagine there will be a massive market for it. What the company is doing now is amplifying the side effects of a medical treatment. When we understand better how it works, it could be used in the treatment of alopecia and other hair growth problems.'

Monday 27 October 2008


Have your say ...

Add your own comment

II'd be willing to pay fr this...but probably not as much as they're going to charge :( I can see why they dont want competition, this is going to be so popular if it really works.
Comment by Katherine Saunt on October 27 15:28

Omg! Wow! I hope it's safe though.
Comment by elle on October 27 18:09

I had heard that botox had beneficial results in the area of alopecia. If this is a similar product then there might be hope for alopecia suffers everywhere
Comment by Christie on November 04 19:05

sounds brilliant however just spent last 2 hours trying to purchase it online with no luck whatsoever! Can you suggest where I might be able to do the online consultation and have it shipped to me?
Veronica McCluskie
Comment by rona mccluskie on April 15 10:01

oh dear
Comment by Lisa on May 22 17:38

Rate this ...

Rate this content

Thanks, your rating has been counted!

  • Current rating:
  • 4/5



April Subscription offer